
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $893.5M | $1.5B | $1.7B | $1.7B | $1.9B | |
Revenue Growth (YoY) | 5.67% | 66.57% | 11.38% | 0.57% | 14.64% | |
Cost of Revenues | $598.6M | $913.2M | $1B | $1.1B | $1.2B | |
Gross Profit | $294.9M | $575.1M | $610.6M | $614.4M | $717M | |
Gross Profit Margin | 33% | 38.64% | 36.83% | 36.86% | 37.52% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $208.6M | $316.7M | $378.8M | $416.2M | $477.7M | |
Other Inc / (Exp) | $366K | $35K | -$29K | $1.4M | $2.3M | |
Operating Expenses | $208.6M | $316.7M | $378.8M | $416.2M | $477.7M | |
Operating Income | $86.3M | $258.3M | $231.8M | $198.2M | $239.4M | |
Net Interest Expenses | $9.4M | $5.8M | $5.9M | $2.2M | $1.5M | |
EBT. Incl. Unusual Items | $77.3M | $252.6M | $225.9M | $197.4M | $240.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $17.9M | $60.1M | $55.3M | $50.4M | $59.2M | |
Net Income to Company | $59.4M | $192.5M | $170.6M | $147M | $180.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $59.4M | $192.5M | $170.6M | $147M | $180.9M | |
Basic EPS (Cont. Ops) | $2.05 | $6.51 | $5.72 | $4.87 | $5.93 | |
Diluted EPS (Cont. Ops) | $2.01 | $6.33 | $5.62 | $4.80 | $5.88 | |
Weighted Average Basic Share | $28.9M | $29.6M | $29.8M | $30.2M | $30.5M | |
Weighted Average Diluted Share | $29.5M | $30.4M | $30.4M | $30.6M | $30.8M | |
EBITDA | $110.8M | $285.7M | $267.7M | $249.2M | $304.1M | |
EBIT | $86.7M | $258.4M | $231.8M | $199.6M | $241.6M | |
Revenue (Reported) | $893.5M | $1.5B | $1.7B | $1.7B | $1.9B | |
Operating Income (Reported) | $86.3M | $258.3M | $231.8M | $198.2M | $239.4M | |
Operating Income (Adjusted) | $86.7M | $258.4M | $231.8M | $199.6M | $241.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $258.9M | $383.3M | $425.7M | $388.5M | $453.7M | |
Revenue Growth (YoY) | 37.24% | 48.07% | 11.05% | -8.74% | 16.81% | |
Cost of Revenues | $166.5M | $234.5M | $269.8M | $249M | $285.2M | |
Gross Profit | $92.4M | $148.8M | $155.8M | $139.4M | $168.6M | |
Gross Profit Margin | 35.69% | 38.83% | 36.61% | 35.9% | 37.15% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $59.5M | $86.4M | $93.1M | $101.2M | $118.9M | |
Other Inc / (Exp) | $72K | -$126K | $181K | $871K | $607K | |
Operating Expenses | $59.5M | $86.4M | $93.1M | $101.2M | $118.9M | |
Operating Income | $32.9M | $62.4M | $62.7M | $38.2M | $49.7M | |
Net Interest Expenses | $2.1M | $388K | $1.5M | $230K | $346K | |
EBT. Incl. Unusual Items | $30.8M | $61.9M | $61.4M | $38.9M | $49.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $6.3M | $17.2M | $15M | $9.4M | $12.4M | |
Net Income to Company | $24.6M | $44.7M | $46.4M | $29.4M | $37.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $24.6M | $44.7M | $46.4M | $29.4M | $37.5M | |
Basic EPS (Cont. Ops) | $0.84 | $1.51 | $1.55 | $0.97 | $1.23 | |
Diluted EPS (Cont. Ops) | $0.82 | $1.47 | $1.53 | $0.96 | $1.22 | |
Weighted Average Basic Share | $29.1M | $29.7M | $29.9M | $30.3M | $30.6M | |
Weighted Average Diluted Share | $30.1M | $30.4M | $30.5M | $30.7M | $30.6M | |
EBITDA | $39.1M | $69.8M | $72.8M | $52.9M | $67M | |
EBIT | $32.9M | $62.3M | $62.9M | $39.1M | $50.3M | |
Revenue (Reported) | $258.9M | $383.3M | $425.7M | $388.5M | $453.7M | |
Operating Income (Reported) | $32.9M | $62.4M | $62.7M | $38.2M | $49.7M | |
Operating Income (Adjusted) | $32.9M | $62.3M | $62.9M | $39.1M | $50.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $893.5M | $1.5B | $1.7B | $1.7B | $1.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $598.6M | $913.2M | $1B | $1.1B | $1.2B | |
Gross Profit | $294.9M | $575.1M | $610.6M | $614.4M | $717M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $208.6M | $316.7M | $378.8M | $416.2M | $477.7M | |
Other Inc / (Exp) | $366K | $35K | -$29K | $1.4M | $2.3M | |
Operating Expenses | $208.6M | $316.7M | $378.8M | $416.2M | $477.7M | |
Operating Income | $86.3M | $258.3M | $231.8M | $198.2M | $239.4M | |
Net Interest Expenses | $9.4M | $5.8M | $5.9M | $2.2M | $1.5M | |
EBT. Incl. Unusual Items | $77.3M | $252.6M | $225.9M | $197.4M | $240.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $17.9M | $60.1M | $55.3M | $50.4M | $59.2M | |
Net Income to Company | $59.4M | $192.5M | $170.6M | $147M | $180.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $59.4M | $192.5M | $170.6M | $147M | $180.9M | |
Basic EPS (Cont. Ops) | $2.04 | $6.51 | $5.72 | $4.87 | $5.93 | |
Diluted EPS (Cont. Ops) | $2.00 | $6.34 | $5.62 | $4.80 | $5.86 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $112.8M | $285.7M | $267.7M | $249.2M | $304.1M | |
EBIT | $86.7M | $258.4M | $231.8M | $199.6M | $241.6M | |
Revenue (Reported) | $893.5M | $1.5B | $1.7B | $1.7B | $1.9B | |
Operating Income (Reported) | $86.3M | $258.3M | $231.8M | $198.2M | $239.4M | |
Operating Income (Adjusted) | $86.7M | $258.4M | $231.8M | $199.6M | $241.6M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.5B | $1.7B | $1.7B | $1.9B | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $913.2M | $1B | $1.1B | $1.2B | -- | |
Gross Profit | $575.1M | $610.6M | $614.4M | $717M | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $316.7M | $378.8M | $416.2M | $477.7M | -- | |
Other Inc / (Exp) | $35K | -$29K | $1.4M | $2.3M | -- | |
Operating Expenses | $316.7M | $378.8M | $416.2M | $477.7M | -- | |
Operating Income | $258.3M | $231.8M | $198.2M | $239.4M | -- | |
Net Interest Expenses | $5.8M | $5.9M | $2.2M | $1.5M | -- | |
EBT. Incl. Unusual Items | $252.6M | $225.9M | $197.4M | $240.1M | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $60.1M | $55.3M | $50.4M | $59.2M | -- | |
Net Income to Company | $192.5M | $170.6M | $147M | $180.9M | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $192.5M | $170.6M | $147M | $180.9M | -- | |
Basic EPS (Cont. Ops) | $6.51 | $5.72 | $4.87 | $5.93 | -- | |
Diluted EPS (Cont. Ops) | $6.34 | $5.62 | $4.80 | $5.86 | -- | |
Weighted Average Basic Share | $118.2M | $119.2M | $120.7M | $122.1M | -- | |
Weighted Average Diluted Share | $121.4M | $121.5M | $122.4M | $123.2M | -- | |
EBITDA | $285.7M | $267.7M | $249.2M | $304.1M | -- | |
EBIT | $258.4M | $231.8M | $199.6M | $241.6M | -- | |
Revenue (Reported) | $1.5B | $1.7B | $1.7B | $1.9B | -- | |
Operating Income (Reported) | $258.3M | $231.8M | $198.2M | $239.4M | -- | |
Operating Income (Adjusted) | $258.4M | $231.8M | $199.6M | $241.6M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $73.1M | $20.7M | $18.2M | $75.8M | $69.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $12.8M | $9.7M | $13.1M | $10M | $10.3M | |
Inventory | $275.8M | $474.3M | $589.5M | $599.1M | $747.2M | |
Prepaid Expenses | $9.6M | $28.2M | $37.4M | $23.9M | $16.8M | |
Other Current Assets | $2.9M | $6.7M | $10.9M | $10.5M | $11.5M | |
Total Current Assets | $374.5M | $541.8M | $669.2M | $729.6M | $864M | |
Property Plant And Equipment | $297.3M | $396.4M | $583.8M | $714.2M | $891.5M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $197.5M | $197.5M | $197.5M | $197.5M | $197.5M | |
Other Intangibles | $60.9M | $60.8M | $60.8M | $58.7M | $58.7M | |
Other Long-Term Assets | $3.5M | $3.3M | $6.2M | $5.6M | $6.3M | |
Total Assets | $933.6M | $1.2B | $1.5B | $1.7B | $2B | |
Accounts Payable | $104.6M | $131.4M | $134.2M | $132.9M | $134.5M | |
Accrued Expenses | $22.5M | $46.7M | $45.4M | $38.3M | $52M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $39.4M | $43.1M | $51.6M | $63.5M | $72.9M | |
Other Current Liabilities | $621K | $1.1M | $2M | $4.8M | $5.3M | |
Total Current Liabilities | $221.7M | $336.5M | $374.8M | $312.8M | $353.3M | |
Long-Term Debt | $109.8M | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $538.7M | $600.2M | $740.9M | $761.9M | $887M | |
Common Stock | $3K | $3K | $3K | $3K | $3K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $394.9M | $599.7M | $776.5M | $943.6M | $1.1B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $394.9M | $599.7M | $776.5M | $943.6M | $1.1B | |
Total Liabilities and Equity | $933.6M | $1.2B | $1.5B | $1.7B | $2B | |
Cash and Short Terms | $73.1M | $20.7M | $18.2M | $75.8M | $69.8M | |
Total Debt | $109.8M | $28.5M | $66M | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $73.1M | $20.7M | $18.2M | $75.8M | $69.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $12.8M | $9.7M | $13.1M | $10M | $10.3M | |
Inventory | $275.8M | $474.3M | $589.5M | $599.1M | $747.2M | |
Prepaid Expenses | $9.6M | $28.2M | $37.4M | $23.9M | $16.8M | |
Other Current Assets | $2.9M | $6.7M | $10.9M | $10.5M | $11.5M | |
Total Current Assets | $374.5M | $541.8M | $669.2M | $729.6M | $864M | |
Property Plant And Equipment | $297.3M | $396.4M | $583.8M | $714.2M | $891.5M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $197.5M | $197.5M | $197.5M | $197.5M | $197.5M | |
Other Intangibles | $60.9M | $60.8M | $60.8M | $58.7M | $58.7M | |
Other Long-Term Assets | $3.5M | $3.3M | $6.2M | $5.6M | $6.3M | |
Total Assets | $933.6M | $1.2B | $1.5B | $1.7B | $2B | |
Accounts Payable | $104.6M | $131.4M | $134.2M | $132.9M | $134.5M | |
Accrued Expenses | $22.5M | $46.7M | $45.4M | $38.3M | $52M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $39.4M | $43.1M | $51.6M | $63.5M | $72.9M | |
Other Current Liabilities | $621K | $1.1M | $2M | $4.8M | $5.3M | |
Total Current Liabilities | $221.7M | $336.5M | $374.8M | $312.8M | $353.3M | |
Long-Term Debt | $109.8M | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $538.7M | $600.2M | $740.9M | $761.9M | $887M | |
Common Stock | $3K | $3K | $3K | $3K | $3K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $394.9M | $599.7M | $776.5M | $943.6M | $1.1B | |
Total Liabilities and Equity | $933.6M | $1.2B | $1.5B | $1.7B | $2B | |
Cash and Short Terms | $73.1M | $20.7M | $18.2M | $75.8M | $69.8M | |
Total Debt | $109.8M | $28.5M | $66M | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $59.4M | $192.5M | $170.6M | $147M | $180.9M | |
Depreciation & Amoritzation | $24.1M | $27.4M | $35.9M | $49.6M | $62.5M | |
Stock-Based Compensation | $7.2M | $9.5M | $9.7M | $12.9M | $11M | |
Change in Accounts Receivable | $8.1M | $5.2M | -$2.7M | $3.3M | -$240K | |
Change in Inventories | $13M | -$198.5M | -$115.2M | -$9.6M | -$148.1M | |
Cash From Operations | $155.9M | $88.9M | $88.9M | $236.1M | $147.5M | |
Capital Expenditures | $28.4M | $60.4M | $124.5M | $118.8M | $148.3M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$28.4M | -$60.4M | -$124.5M | -$118.8M | -$148.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$667K | -$112.3M | -$838K | -$863K | -$873K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$754K | -$2.9M | -$4.7M | -$2.5M | -$7.6M | |
Cash From Financing | -$123.9M | -$80.9M | $33.2M | -$59.6M | -$5.4M | |
Beginning Cash (CF) | $69.6M | $73.1M | $20.7M | $18.2M | $75.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $3.6M | -$52.5M | -$2.5M | $57.7M | -$6.1M | |
Ending Cash (CF) | $73.1M | $20.7M | $18.2M | $75.8M | $69.8M | |
Levered Free Cash Flow | $127.5M | $28.4M | -$35.6M | $117.3M | -$753K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $24.6M | $44.7M | $46.4M | $29.4M | $37.5M | |
Depreciation & Amoritzation | $6.2M | $7.5M | $9.9M | $13.7M | $16.7M | |
Stock-Based Compensation | $2.1M | $1.7M | $149K | $2.5M | $2.8M | |
Change in Accounts Receivable | $3.8M | -$575K | $1.9M | $377K | $12K | |
Change in Inventories | -$29.8M | -$88.7M | $2.7M | -$35.7M | -$56.9M | |
Cash From Operations | -$682K | -$101.7M | $1.8M | -$4.4M | -$43.1M | |
Capital Expenditures | $7.9M | $20.7M | $41.5M | $27.5M | $39.9M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$7.9M | -$20.7M | -$41.5M | -$27.5M | -$39.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | $129.7M | -$219K | -$212K | $65.8M | -$227K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$219K | -$194K | -$188K | -$55K | -- | |
Cash From Financing | $5.4M | $28.3M | $7.4M | $545K | -$65K | |
Beginning Cash (CF) | $76.3M | $114.7M | $50.4M | $107.2M | $152.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$3.2M | -$94M | -$32.2M | -$31.3M | -$83.1M | |
Ending Cash (CF) | $73.1M | $20.7M | $18.2M | $75.8M | $69.8M | |
Levered Free Cash Flow | -$8.6M | -$122.4M | -$39.6M | -$31.9M | -$83.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $59.4M | $192.5M | $170.6M | $147M | $180.9M | |
Depreciation & Amoritzation | $24.1M | $27.4M | $35.9M | $49.6M | $62.5M | |
Stock-Based Compensation | $7.2M | $9.5M | $9.7M | $12.9M | $11M | |
Change in Accounts Receivable | $8.1M | $5.2M | -$2.7M | $3.3M | -$240K | |
Change in Inventories | $13M | -$198.5M | -$115.2M | -$9.6M | -$148.1M | |
Cash From Operations | $155.9M | $88.9M | $88.9M | $236.1M | $147.5M | |
Capital Expenditures | $28.4M | $60.4M | $124.5M | $118.8M | $148.3M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$28.4M | -$60.4M | -$124.5M | -$118.8M | -$148.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$667K | -$112.3M | -$838K | -$863K | -$873K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$754K | -$2.9M | -$4.7M | -$2.5M | -$7.6M | |
Cash From Financing | -$123.9M | -$80.9M | $33.2M | -$59.6M | -$5.4M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $3.6M | -$52.5M | -$2.5M | $57.7M | -$6.1M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $127.5M | $28.4M | -$35.6M | $117.3M | -$753K |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $192.5M | $170.6M | $147M | $180.9M | -- | |
Depreciation & Amoritzation | $27.4M | $35.9M | $49.6M | $62.5M | -- | |
Stock-Based Compensation | $9.5M | $9.7M | $12.9M | $11M | -- | |
Change in Accounts Receivable | $5.2M | -$2.7M | $3.3M | -$240K | -- | |
Change in Inventories | -$198.5M | -$115.2M | -$9.6M | -$148.1M | -- | |
Cash From Operations | $88.9M | $88.9M | $236.1M | $147.5M | -- | |
Capital Expenditures | $60.4M | $124.5M | $118.8M | $148.3M | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$60.4M | -$124.5M | -$118.8M | -$148.2M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$112.3M | -$838K | -$863K | -$873K | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$2.9M | -$4.7M | -$2.5M | -$7.6M | -- | |
Cash From Financing | -$80.9M | $33.2M | -$59.6M | -$5.4M | -- | |
Beginning Cash (CF) | $277M | $106.8M | $181.1M | $349.5M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$52.5M | -$2.5M | $57.7M | -$6.1M | -- | |
Ending Cash (CF) | $224.6M | $104.3M | $238.8M | $343.4M | -- | |
Levered Free Cash Flow | $28.4M | -$35.6M | $117.3M | -$753K | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.